Matuguina, Mark John .

HRN: 24-79-98  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/11/2024
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
04/11/2024
04/18/2024
PO
6ml
Q8h
Laceration
Waiting Final Action 
04/12/2024
CEFUROXIME 750MG (VIAL)
04/12/2024
04/18/2024
IVT
750mg
Q8
Lacerated Wound, Upper Lip
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: